HPC News, Musings and Educational Articles

Dr Russo has been campaigning for private health cover to be expanded to bronze and silver policies. Carolyn Ward, one of Dr Russo's patients, expressed her concerns about the federal reforms that might affect her ability to claim for ongoing costs related to her device. A Call for Insurance Reforms to Expand Cover for Pain Devices - 2nd November 2018
Dr Russo has been campaigning for private health cover to be expanded to bronze and silver policies. Carolyn Ward, one of Dr Russo's patients, expressed her concerns about the federal reforms that might affect her ability to claim for ongoing costs related to her device.
Website: Newcastle Herald
Monday 5th November is “Colour the World Orange” Day 2018 – a day to raise awareness for Complex Regional Pain Syndrome (CRPS). Colour the World Orange for CRPS Awareness - 2nd November 2018
Monday 5th November is “Colour the World Orange” Day 2018 – a day to raise awareness for Complex Regional Pain Syndrome (CRPS).
Dr Russo was recently interviewed by the ABC. He expressed his concerns about the proposed changes to private health coverage for chronic pain treatment. Dr Russo Speaks with ABC News on Proposed Private Health Insurance Changes - 2nd October 2018
Dr Russo was recently interviewed by the ABC. He expressed his concerns about the proposed changes to private health coverage for chronic pain treatment.
Website: ABC News
Being the Director-at-Large for the Neuromodulation Society of Australia and New Zealand (NSANZ) New South Wales, Dr Marc Russo has seen first-hand what the Federal Government is proposing in relation to private health insurance funding changes. Chronic Pain Woes Under Federal Government’s New Proposal - 20th September 2018
Being the Director-at-Large for the Neuromodulation Society of Australia and New Zealand (NSANZ) New South Wales, Dr Marc Russo has seen first-hand what the Federal Government is proposing in relation to private health insurance funding changes.
For more information download this document
By Marc Russo, Peter Georgius & Danielle Santarelli

Complex Regional Pain Syndrome (CRPS) is an enigmatic disease and has defied a clear unified pathological explanation to date. It is a devastating, painful condition that may develop in a limb after an injury, surgery or other trauma. What we do know about the disease is that is involves disturbances to multiple body systems and biological processes, causing them to behave abnormally. A New Hypothesis for the Pathophysiology of Complex Regional Pain Syndrome - 10th September 2018
By Marc Russo, Peter Georgius & Danielle Santarelli Complex Regional Pain Syndrome (CRPS) is an enigmatic disease and has defied a clear unified pathological explanation to date. It is a devastating, painful condition that may develop in a limb after an injury, surgery or other trauma. What we do know about the disease is that is involves disturbances to multiple body systems and biological processes, causing them to behave abnormally.
For more information download this document
There is increasing evidence for a lack of long term benefit from conventional “pure mu” opioids when used for chronic non-cancer pain, along with increasing concern of misuse, abuse and diversion, and opioid-related deaths. What is the appropriate response to reviewing a patient who has been prescribed a moderate to high dose of conventional pure mu opioids for a number of years and is still reporting significant pain? It is appropriate to consider a trial of deprescribing.
Deprescribing Opioids - 19th July 2018
There is increasing evidence for a lack of long term benefit from conventional “pure mu” opioids when used for chronic non-cancer pain, along with increasing concern of misuse, abuse and diversion, and opioid-related deaths. What is the appropriate response to reviewing a patient who has been prescribed a moderate to high dose of conventional pure mu opioids for a number of years and is still reporting significant pain? It is appropriate to consider a trial of deprescribing.
Currently, Hunter Pain Clinic is assessing where the role of medicinal cannabis might lie in terms of treatment of persistent non-cancer pain. Medicinal Cannabis - 19th July 2018
Currently, Hunter Pain Clinic is assessing where the role of medicinal cannabis might lie in terms of treatment of persistent non-cancer pain.
Neuromodulation (or neurostimulation) represents an advanced pain management therapy for patients with chronic, refractory pain. This article provides an overview of the history of neuromodulation, spinal cord stimulation, peripheral nerve stimulation and other forms of neurostimulation, as well as updates in neuromodulation therapy. Neuromodulation: History and Updates - 22nd May 2018
Neuromodulation (or neurostimulation) represents an advanced pain management therapy for patients with chronic, refractory pain. This article provides an overview of the history of neuromodulation, spinal cord stimulation, peripheral nerve stimulation and other forms of neurostimulation, as well as updates in neuromodulation therapy.
Dr Russo and the Executive Board of NSANZ meeting with Mr Omar Ishrak, CEO of the Medtronic company.
Neuromodulation Society of Australia and New Zealand meeting - 17th April 2018
Dr Russo and the Executive Board of NSANZ meeting with Mr Omar Ishrak, CEO of the Medtronic company.
Dr Russo recently implanted Australia's first Intellis device - the world's smallest spinal cord stimulator system. 9 News interviewed Dr Russo and his patient. The article can be viewed on the 9 News website. Dr Russo Implants Australia's First Intellis Device - 10th April 2018
Dr Russo recently implanted Australia's first Intellis device - the world's smallest spinal cord stimulator system. 9 News interviewed Dr Russo and his patient. The article can be viewed on the 9 News website.
Website: 9 News


News Archives >>